Nirsevimab for Prevention of Hospitalizations Due to RSV in Infants
Nirsevimab for Prevention of Hospitalizations Due to RSV in Infants
About this item
Full title
Author / Creator
Drysdale, Simon B. , Cathie, Katrina , Flamein, Florence , Knuf, Markus , Collins, Andrea M. , Hill, Helen C. , Kaiser, Friedrich , Cohen, Robert , Pinquier, Didier , Felter, Christian T. , Vassilouthis, Natalya C. , Jin, Jing , Bangert, Mathieu , Mari, Karine , Nteene, Rapi , Wague, Sophie , Roberts, Michelle , Tissières, Pierre , Royal, Simon , Faust, Saul N. and HARMONIE Study Group
Publisher
United States: Massachusetts Medical Society
Journal title
Language
English
Formats
Publication information
Publisher
United States: Massachusetts Medical Society
Subjects
More information
Scope and Contents
Contents
Nirsevimab, a monoclonal antibody targeting RSV, led to decreased hospitalizations for RSV-associated lower respiratory tract infection in infants during their first RSV season, in an open-label, pragmatic trial.
Alternative Titles
Full title
Nirsevimab for Prevention of Hospitalizations Due to RSV in Infants
Authors, Artists and Contributors
Author / Creator
Cathie, Katrina
Flamein, Florence
Knuf, Markus
Collins, Andrea M.
Hill, Helen C.
Kaiser, Friedrich
Cohen, Robert
Pinquier, Didier
Felter, Christian T.
Vassilouthis, Natalya C.
Jin, Jing
Bangert, Mathieu
Mari, Karine
Nteene, Rapi
Wague, Sophie
Roberts, Michelle
Tissières, Pierre
Royal, Simon
Faust, Saul N.
HARMONIE Study Group
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_hal_primary_oai_HAL_hal_04775428v1
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_hal_primary_oai_HAL_hal_04775428v1
Other Identifiers
ISSN
0028-4793
E-ISSN
1533-4406
DOI
10.1056/NEJMoa2309189
